PHIO PHIO PHARMACEUTICALS CORP
FollowCOM NEW (common), issuer CIK 1533040
7 managers (7 13F filers) reported a position in PHIO shares at 2024-09-30, 28,506 shares in all. 7 filers opened a position and 0 filers sold out during the quarter.
- Managers
- 7
- 13F filers
- 7
- New
- 7
- Added
- 0
- Reduced
- 0
- Sold out
- 0
- Shares held by filers
- 28,506
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q3 2024
Filers in the available 13F reports with a share position at 2024-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 25,131 | $86.7K | 1.2% | new | 13F-HRTimeline |
| UBS Group AGin group UBS Group AG | 1,685 | $5.81K | <0.01% | new | 13F-HRTimelineGroup |
| Tower Research Capital LLC (TRC)in group Tower Research Capital LLC (T… | 1,174 | $4.05K | <0.01% | new | 13F-HRTimelineGroup |
| Nordwand Advisors, LLC | 500 | $1.73K | <0.01% | new | 13F-HRTimeline |
| Activest Wealth Management | 9 | $31 | <0.01% | new | 13F-HRTimeline |
| BANK OF AMERICA CORP /DE/in group BANK OF AMERICA CORP /DE/ | 7 | $24 | <0.01% | new | 13F-HRTimelineGroup |
| CONCOURSE FINANCIAL GROUP SECURITIES, I… | 0 | $0 | 0% | new | 13F-HRTimelineValue filed as zero, left out of ratios. Amount filed as zero, left out of ratios. |